JO
TNYA icon

John Overdeck’s Tenaya Therapeutics TNYA Stock Holding History

John Overdeck’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$281K Sell
380,790
-899,600
-70% -$683K ﹤0.01% 4569
2026
Q1 		$887K Buy
1,280,390
+14,315
+1% +$10.6K ﹤0.01% 3354
2025
Q4 		$901K Buy
1,266,075
+355,507
+39% +$483K ﹤0.01% 2996
2025
Q3 		$1.48M Buy
910,568
+435,781
+92% +$439K ﹤0.01% 2331
2025
Q2 		$290K Buy
474,787
+107,158
+29% +$54.5K ﹤0.01% 2801
2025
Q1 		$210K Buy
367,629
+322,858
+721% +$319K ﹤0.01% 2837
2024
Q4 		$64K Sell
44,771
-9,943
-18% -$22.3K ﹤0.01% 3021
2024
Q3 		$106K Sell
54,714
-52,865
-49% -$149K ﹤0.01% 2894
2024
Q2 		$333K Sell
107,579
-766
-0.7% -$3.16K ﹤0.01% 2546
2024
Q1 		$567K Sell
108,345
-81,536
-43% -$390K ﹤0.01% 2274
2023
Q4 		$615K Sell
189,881
-61,705
-25% -$133K ﹤0.01% 2353
2023
Q3 		$642K Buy
251,586
+8,987
+4% +$37.6K ﹤0.01% 2166
2023
Q2 		$1.42M Buy
242,599
+123,876
+104% +$720K ﹤0.01% 1726
2023
Q1 		$338K Buy
118,723
+38,505
+48% +$108K ﹤0.01% 2372
2022
Q4 		$161K Buy
80,218
+46,919
+141% +$115K ﹤0.01% 2433
2022
Q3 		$97K Buy
+33,299
New +$155K ﹤0.01% 2239

Other funds holding TNYA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EAM
Empery Asset Management New York $86.5M AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
BGM
Burkehill Global Management New York $2.77B AUM 65.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

John Overdeck's TNYA Position: Q2 2026 in Review

John Overdeck reduced its Tenaya Therapeutics (TNYA) stake by 70% in Q2 2026, selling an estimated $683K and leaving 380,790 shares worth $281K. The position accounts for ﹤0.01% of the portfolio, ranked #4569.

John Overdeck first reported a position in TNYA in Q3 2022 and has held it in 16 quarters since. The position peaked at $1.48M in Q3 2025. 101 funds tracked by Wall St. Rank hold TNYA as of Q2 2026.

  • John Overdeck held 380,790 shares of Tenaya Therapeutics worth $281K as of Q2 2026.
  • John Overdeck sold 899,600 Tenaya Therapeutics shares in Q2 2026, an estimated $683K.
  • Tenaya Therapeutics made up ﹤0.01% of John Overdeck's portfolio in Q2 2026, its #4569 holding.
  • John Overdeck first reported a position in Tenaya Therapeutics in Q3 2022 and has held it in 16 quarters since.
  • John Overdeck's Tenaya Therapeutics position peaked at $1.48M in Q3 2025.
  • 101 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.